JP2014524450A5 - - Google Patents

Download PDF

Info

Publication number
JP2014524450A5
JP2014524450A5 JP2014526385A JP2014526385A JP2014524450A5 JP 2014524450 A5 JP2014524450 A5 JP 2014524450A5 JP 2014526385 A JP2014526385 A JP 2014526385A JP 2014526385 A JP2014526385 A JP 2014526385A JP 2014524450 A5 JP2014524450 A5 JP 2014524450A5
Authority
JP
Japan
Prior art keywords
pacap
given
concentration
peptide
molecular adjuvant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014526385A
Other languages
English (en)
Japanese (ja)
Other versions
JP2014524450A (ja
JP6077541B2 (ja
Filing date
Publication date
Priority claimed from CU2011000167A external-priority patent/CU24075B1/es
Application filed filed Critical
Publication of JP2014524450A publication Critical patent/JP2014524450A/ja
Publication of JP2014524450A5 publication Critical patent/JP2014524450A5/ja
Application granted granted Critical
Publication of JP6077541B2 publication Critical patent/JP6077541B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014526385A 2011-08-26 2012-08-24 ワクチンのための分子アジュバントとしてのpacapの使用 Active JP6077541B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CU2011-0167 2011-08-26
CU2011000167A CU24075B1 (es) 2011-08-26 2011-08-26 Composición vacunal que comprende el péptido activador de la adenilato ciclasa de pituitaria como adyuvante molecular.
PCT/CU2012/000004 WO2013029570A1 (es) 2011-08-26 2012-08-24 Uso del pacap como adyuvante molecular para vacunas

Publications (3)

Publication Number Publication Date
JP2014524450A JP2014524450A (ja) 2014-09-22
JP2014524450A5 true JP2014524450A5 (cg-RX-API-DMAC7.html) 2015-04-02
JP6077541B2 JP6077541B2 (ja) 2017-02-08

Family

ID=47046313

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014526385A Active JP6077541B2 (ja) 2011-08-26 2012-08-24 ワクチンのための分子アジュバントとしてのpacapの使用

Country Status (20)

Country Link
US (1) US9549977B2 (cg-RX-API-DMAC7.html)
EP (1) EP2749291B1 (cg-RX-API-DMAC7.html)
JP (1) JP6077541B2 (cg-RX-API-DMAC7.html)
KR (1) KR101857705B1 (cg-RX-API-DMAC7.html)
CN (1) CN103874510A (cg-RX-API-DMAC7.html)
AU (1) AU2012303887B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014004620B1 (cg-RX-API-DMAC7.html)
CA (1) CA2844898C (cg-RX-API-DMAC7.html)
CL (1) CL2014000386A1 (cg-RX-API-DMAC7.html)
CU (1) CU24075B1 (cg-RX-API-DMAC7.html)
ES (1) ES2648337T3 (cg-RX-API-DMAC7.html)
MX (1) MX351725B (cg-RX-API-DMAC7.html)
MY (1) MY191697A (cg-RX-API-DMAC7.html)
NO (1) NO2749291T3 (cg-RX-API-DMAC7.html)
PH (1) PH12014500397B1 (cg-RX-API-DMAC7.html)
PT (1) PT2749291T (cg-RX-API-DMAC7.html)
RU (1) RU2580294C2 (cg-RX-API-DMAC7.html)
SG (1) SG11201400215SA (cg-RX-API-DMAC7.html)
WO (1) WO2013029570A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201401271B (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20190060057A (ko) 2017-11-24 2019-06-03 유병희 웰빙 무드등
CN114173874B (zh) * 2019-05-14 2025-07-25 千寿制药株式会社 含pacap肽或pacap的稳定化肽的神经营养性角膜炎的预防或治疗用组合物
CN117617183B (zh) * 2023-11-29 2025-09-05 中国医学科学院医药生物技术研究所 突变体斑马鱼在制备凝血功能障碍疾病的动物模型中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE65568B1 (en) * 1990-10-22 1995-11-01 Unilever Plc Vaccine compositions for fish
WO2001023420A2 (en) * 1999-09-28 2001-04-05 Bayer Corporation Pituitary adenylate cyclase activating peptide (pacap) receptor 3 (r3) agonists and their pharmacological methods of use
GB0427267D0 (en) * 2004-12-13 2005-01-12 Maria Teresa De Magistris Peptide adjuvants
CU23557A1 (es) * 2005-11-22 2010-07-20 Ct Ingenieria Genetica Biotech Neuropéptidos para el cultivo de organismos acuáticos
US8916517B2 (en) * 2009-11-02 2014-12-23 The Administrators Of The Tulane Educational Fund Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use
CN103255089B (zh) * 2013-05-03 2015-08-05 中国水产科学研究院黄海水产研究所 一株强毒迟缓爱德华氏菌疫苗株及其应用

Similar Documents

Publication Publication Date Title
Zhu et al. Single-walled carbon nanotubes as candidate recombinant subunit vaccine carrier for immunization of grass carp against grass carp reovirus
JP2012513479A5 (cg-RX-API-DMAC7.html)
ES2488941T3 (es) Vectores y constructos de liberación de antígenos de virus de la gripe
Wang et al. The protective immunity against grass carp reovirus in grass carp induced by a DNA vaccination using single-walled carbon nanotubes as delivery vehicles
Xu et al. Superior protection conferred by inactivated whole virus vaccine over subunit and DNA vaccines against salmonid alphavirus infection in Atlantic salmon (Salmo salar L.)
Ross et al. Single dose combination nanovaccine provides protection against influenza A virus in young and aged mice
JP2012503011A5 (ja) 慢性c型肝炎ウイルス感染症のための酵母系免疫治療組成物
JP2017523225A5 (cg-RX-API-DMAC7.html)
Jiang et al. Hantavirus Gc induces long-term immune protection via LAMP-targeting DNA vaccine strategy
Kim et al. Comparison of the efficacy of Poly (I: C) immunization with live vaccine and formalin-killed vaccine against viral hemorrhagic septicemia virus (VHSV) in olive flounder (Paralichthys olivaceus)
JP2016504315A5 (cg-RX-API-DMAC7.html)
Myoung Two years of COVID-19 pandemic: where are we now?
Louz et al. Animal models in virus research: their utility and limitations
JP2010506926A5 (cg-RX-API-DMAC7.html)
JP2014524450A5 (cg-RX-API-DMAC7.html)
JP2016528176A5 (cg-RX-API-DMAC7.html)
US11304989B2 (en) Peptides for use in the treatment of viral infections
Gillam et al. Epitope selection and their placement for increased virus neutralization in a novel vaccination strategy for porcine epidemic diarrhea virus utilizing the Hepatitis B virus core antigen
Kim et al. Protection of olive flounder, Paralichthys olivaceus, against viral hemorrhagic septicemia virus (VHSV) by immunization with NV gene-knockout recombinant VHSV
RU2014111465A (ru) Применение расар в качестве молекулярного адъюванта для вакцин
JP2019534242A5 (cg-RX-API-DMAC7.html)
US9872895B2 (en) TLR5 ligands, therapeutic methods, and compositions related thereto
JP2020500837A5 (cg-RX-API-DMAC7.html)
Martinez-Alonso et al. Immune responses elicited in rainbow trout through the administration of infectious pancreatic necrosis virus-like particles
Farhana et al. Sars-CoV-2leader-RNA-primed Transcription and RNA-Splicing prevention, control and Treatment